At a glance
ClinicalIndex Comparison RecordN/ACompleted· 105 enrolled
Drug / intervention
Erchonia FX-405™ Laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of the Effect of the Erchonia FX-405™ on Treating Toenail Onychomycosis Clinical Study
In Brief
A clinical study evaluating Erchonia FX-405™ Laser for Onychomycosis. Completed, enrolled 105 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether low level laser light is effective in the treatment of toenail fungus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnychomycosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2011
First PostedFeb 2012
Primary CompletionApr 2012
TodayJul 2026
First PostedFeb 17, 2012
Enrollment StartApr 1, 2011
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 14.4 years ago
Interventions
Erchonia FX-405™ Laserdevice
The Erchonia FX-405™ dual diode laser light is directed at the great toenail at a distance of approximately 6 inches above the toenail. The dual wavelengths of 405 nm and 635 nm are activated simultaneously for 10 minutes of total treatment administration time.